RxDoctor Payments Data

Caroline Wehby

Physician Assistant · Nashville, TNNPI 1295385623

Payments from drug & device makers

$780in general payments, 2019–2025

Across 73 payments — averaging $10.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$343
  • Otsuka America Pharmaceutical, Inc.$209
  • Alkermes, Inc.$94
  • Teva Pharmaceuticals USA, Inc.$38
  • Vanda Pharmaceuticals Inc.$29
  • Neurocrine Biosciences, Inc.$20
  • plus $47 from 3 others

What the payments were for

  • Food & beverage$780100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$780 in reported general payments places this provider in the 60th percentile of 2,404 physician assistant providers in Tennessee.

See all physician assistant providers in Tennessee

Medicare billing

Part B allowed, 2024
$12,171
Medicare patients
20
Services billed
148

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
AustedoDeutetrabenazine13$186,549
RexultiBrexpiprazole38$54,513
VraylarCariprazine Hcl32$47,572
DayvigoLemborexant12$7,253
Desvenlafaxine Succinate ErDesvenlafaxine Succinate78$6,620
Olanzapine52$2,372
Lurasidone Hcl16$1,983
Fluoxetine Hcl78$1,717
Mirtazapine67$1,634
Duloxetine Hcl51$1,599
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine17$1,532
Methylphenidate Hcl34$1,269
Prazosin Hcl41$1,257
Lamotrigine56$1,244
Quetiapine Fumarate54$1,097

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Teva Pharmaceuticals USA, Inc.Austedo$38$186,54913 claims
Otsuka America Pharmaceutical, Inc.Rexulti$209$54,51338 claims
AbbVieVraylar$343$47,57232 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 2,404 physician assistant providers in Tennessee.

Other physician assistant in Nashville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →